Triggering Innate Immune Receptors as New Therapies in Alzheimer’s Disease and Multiple Sclerosis

Multiple sclerosis and Alzheimer’s disease are two complex neurodegenerative diseases involving the immune system. So far, available treatments provide at best mild improvements to patients’ conditions. For decades now, a new set of molecules have been used to modulate and regulate the innate immuni...

Descripción completa

Detalles Bibliográficos
Autores principales: Piec, Pierre-Alexandre, Pons, Vincent, Rivest, Serge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393987/
https://www.ncbi.nlm.nih.gov/pubmed/34440933
http://dx.doi.org/10.3390/cells10082164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393987/
https://www.ncbi.nlm.nih.gov/pubmed/34440933
http://dx.doi.org/10.3390/cells10082164

Ejemplares similares